top of page
Mission
To provide a unique GI cancer immunotherapy through a safe, and targeted nanomedical solution that overcomes T-cell exhaustion.
ImmuNovation
Precision ImmunOncology

Restoring immunity control of GI cancers
TNM Differentiation
TNM design engages innate & adaptive immunities:
-
T helper induction grants memory & cytotoxic responses
TNM
-
Uses peptides from “survival proteins”
TNM
-
Delivers danger signals with peptides
-
Targets DC major tumor-induced immunosuppression
TNM prime & activate DC
By providing the three signals:
-
MHC-peptide
-
costimulatory molecules to engage with helper cells
-
cytokine sitimulus

bottom of page